Biosimilars: Current Situation & Future Prospects, Worldwide - PowerPoint PPT Presentation

About This Presentation
Title:

Biosimilars: Current Situation & Future Prospects, Worldwide

Description:

Biosimilars: Current Situation & Future Prospects, Worldwide – PowerPoint PPT presentation

Number of Views:527

less

Transcript and Presenter's Notes

Title: Biosimilars: Current Situation & Future Prospects, Worldwide


1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, industry research, SWOT analysis, and
so on Aarkstore.com is in the forefront as it
is enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Category
  • Pharmaceuticals Healthcare Market Research
    Reports http//www.aarkstore.co
    m/market-sector-reports/Pharmaceuticals--Healthca
    re-7.html

3
Report
2013 Biosimilars Current Situation Future
Prospects, Worldwide Aarkstore.in
http//aarkstore.in/Biosimilars-Current-Situati
on-Future-Prospects-Worldwide.html
4
Request Sample
http//www.aarkstore.com/Report/SampleRequest.asp?
RptId192195
5
Summary
  • The engine of the biosimilar sector is the
    same as with small molecule drugs, patent expiry.
    On this basis, prospects for biosimilars look
    good, with the vast majority of leading
    originator brands in the global biologics market
    expected to lose some degree of protection by
    2019. All major countries now make provision for
    an abbreviated biosimilar development and
    regulatory pathway. Funds are flowing into the
    sector and many new partnership agreements
    signed. Everything in the biosimilar garden might
    look rosy, but what is the reality?


  • More

6
Table of Contents
  • Executive Summary 1. Introduction
    Biosimilarity Rationale for biosimilars
    Regulatory guidelines Types of biosimilars
    Lack of standardisation Market situation 2.
    Safety Concerns Issues with biosimilars Issues
    with originator products Immunogenicity

    More

7
Latest Reports
http//www.aarkstore.com/publishers/JustPharmaRe
ports-12.htmlRisk Sharing and Other Forms of
Managed Entry Agreements for Medicines,
Worldwide  Pharmaceutical Pricing
Distribution in Japan, 2012 Update  Biosimilars
Current Situation Future Prospects,
Worldwide  Orphan Drugs in Europe Pricing,
Reimbursement, Funding Market Access Issues,
2011 Edition  Market Access Korea Breaking
into the Developed Worlds Fastest Growing
Pharmaceutical Market
8
(No Transcript)
9
Contact us
For More details about above other Reports
please contact Lavanya Aarkstore.com Contact
Marketing team Mob.No.918149852585 Email
Customersupport_at_aarkstore.com URL
http//www.aarkstore.com
http//aarkstore.in/
Write a Comment
User Comments (0)
About PowerShow.com